Skip to main content
. 2014 Feb 9;62(6):495–500. doi: 10.1007/s00005-014-0277-y

Table 2.

Levels of TNF-α, IL-1β and IL-17 (pg/ml) in GCF of patients in first and second term of study

Clinical indices First term of study Second term of study
Group 1 (n = 24) Group 2 (n = 14) Group 1 (n = 24) Group 2 (n = 14)
Subgroup 1A (n = 18) Subgroup 1B (n = 6)
TNF-α (pg/ml) 5.52 ± 0.94 5.42 ± 0.87 2.34 ± 0.87* 5.49 ± 0.84 5.27 ± 0.94
IL-1β (pg/ml) 20.74 ± 2.71 20.16 ± 2.46 6.83 ± 1.51* 19.86 ± 1.98 19.63 ± 2.21
IL-17 (pg/ml) 17.58 ± 3.23 17.23 ± 3.15 9.35 ± 1.71* 16.62 ± 2.29 15.93 ± 2.37

* The difference between the first and the second term is statistically significant in a given group of patients